Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2009
11/03/2009US7612166 Fluorous capping reagents and methods for peptide purification
11/03/2009US7612113 Hydroxy tetrahydro-naphthalenylurea derivatives
11/03/2009CA2427579C Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
10/2009
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009101201A3 Mixtures of metal hydrides and ionic liquids and uses of such mixtures
10/29/2009US20090270508 GluR2 receptor modulators
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009CN101565412A Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
10/27/2009US7608736 Process for preparing acylsulfamoylbenzamides
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009129246A2 Compositions and methods for preparing and using same
10/22/2009WO2009128088A2 Preparation of 2-(2-alkoxy phenoxy) ethylamine, an intermediate of carvedilol and tamsulosin
10/22/2009WO2009127822A2 Bis-aryl compounds for use as medicaments
10/22/2009WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009US20090264533 Methods and Compositions for Modulating RHO-Mediated Gene Transcription
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090261043 Chelating compounds and immobilized tethered chelators
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2721452A1 Bis-aryl compounds for use as medicaments
10/22/2009CA2721203A1 Inhibitors of protein phosphatase-1 and uses thereof
10/22/2009CA2720671A1 Compositions and methods for preparing and using same
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/20/2009US7605182 Compounds that selectively bind to membranes of apoptotic cells
10/20/2009CA2721712A1 Herbicidal compounds based on n-azinyl-n'-phenylsulfonylureas
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/15/2009WO2009125606A1 Pai-1 inhibitor
10/15/2009WO2009124962A2 Sulfonamides
10/15/2009US20090258884 Substituted amides
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2720096A1 Pai-1 inhibitor
10/14/2009CN100548976C Sulfonamide derivatives for the treatment of diseases
10/13/2009US7601874 Antiinflammatory agents; antiarthritic agents; brain disorders; multiple sclerosis; gout; inflammatory bowel disorders; gastrointestinal disorders; psoriasis; antiallergens; autoimmune disease
10/13/2009US7601480 Photoactive compounds
10/13/2009CA2429844C Mch antagonists and their use in the treatment of obesity
10/13/2009CA2341678C Potassium channel inhibitors and method
10/08/2009WO2009124022A1 2 -aminotetralin derivatives as mu opioid receptor antagonists
10/08/2009US20090253739 Amine Derivatives
10/08/2009US20090253669 Substituted Sulfonamide Compounds
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/07/2009EP0980353B2 Cationically polymerizable compositions capable of being coated by electrostatic assistance
10/07/2009CN101553461A 4-substituted phenoxyphenylacetic acid derivatives
10/07/2009CN100546977C New compounds for the inhibition of rotamases and use thereof
10/07/2009CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs
10/06/2009US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
10/06/2009US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
10/06/2009US7598269 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanesulfonic acid; reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
10/06/2009US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
10/06/2009CA2301377C N-aroylphenylalanine derivatives
10/01/2009WO2009119858A1 Benzene compound, and use thereof for medical purposes
10/01/2009WO2009118292A1 Arylsulfonamide-based matrix metalloprotease inhibitors
10/01/2009WO2009118168A1 Substituted 4-aminocyclohexane derivatives
10/01/2009US20090247627 Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists
10/01/2009US20090247506 Antibacterial agents
10/01/2009CA2719735A1 Substituted 4-aminocyclohexane derivatives
10/01/2009CA2719457A1 Arylsulfonamide-based matrix metalloprotease inhibitors
09/2009
09/30/2009EP1644324B1 Process for preparing acylsulfamoylbenzamides
09/30/2009CN101544585A Method for preparing (Z)-4-(2-bromovinyl) benzenesulfonimide
09/29/2009US7595399 Tyrosine derivatives
09/29/2009US7595343 Inhibitors of histone deacetylase
09/29/2009US7595309 For therapy of bacterial infections and neoplasms,
09/24/2009WO2009115257A1 Substituted sulfonamide derivatives
09/24/2009WO2009096701A3 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
09/24/2009WO2008144660A3 Chemically cross linked ionomer membrane
09/24/2009CA2718551A1 Substituted sulfonamide derivatives
09/23/2009EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same
09/23/2009EP2102153A1 Ampa receptor potentiators
09/23/2009EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/23/2009CN101541742A Trypsin-like serine protease inhibitors, and their preparation and use
09/23/2009CN101541741A AMPA receptor potentiators
09/23/2009CN101538230A Beta-amino ketones compound with anti-diabetic activity
09/23/2009CN101538226A Method for synthesizing optically active alpha-hydroxyl-beta-phenmethyl-beta-amino acid derivative
09/22/2009US7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists
09/22/2009US7592368 HIV aspartyl protease inhibitors; solubility, bioavailability; viral and HIV infections
09/17/2009US20090234154 Process for the preparation of tamsulosin and intermediates thereof
09/17/2009US20090233909 Sulfonamide compounds as cysteine protease inhibitors
09/16/2009EP2100876A2 New compounds for the inhibition of rotamases and use thereof
09/16/2009EP2099747A1 Radiolabelling via fluorination of aziridines
09/16/2009EP1858865B1 Substituted n-sulfonylaminophenylethyl-2-phenoxy acetamide compounds
09/16/2009EP1562897B1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease
09/16/2009CN100540571C Water- and oil-repellent fluoroacrylates
09/16/2009CN100540547C Inhibitors of histone deacetylase
09/15/2009US7589126 Useful as potent and selective activated blood coagulation factor X inhibitors, anticoagulants; for example, ethyl [4-[2-[2-hydroxy-5-(N-hydroxycarbamimidoyl)benzenesulfonyl-amino]ethyl]-2'-methanesulfonylbiphenyl-3-yloxy]acetate; brain and cardiovascular disorders
09/15/2009US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
09/15/2009CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors
09/11/2009WO2009111280A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
09/11/2009WO2009111279A1 Pyrazole [3, 4-b] pyridine raf inhibitors
09/11/2009WO2009111277A1 Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
09/11/2009CA2716952A1 Pyrazole [3,4-b] pyridine raf inhibitors
09/11/2009CA2716951A1 Raf inhibitor compounds and methods of use thereof
09/11/2009CA2716949A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
09/11/2009CA2716947A1 Imidazo [4,5-b] pyridine derivatives used as raf inhibitors
09/10/2009US20090227681 Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl) cyclopropane-1-sulfonamide and uses thereof
09/10/2009US20090227604 Vitamin d receptor modulators
09/09/2009EP2098503A1 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2-methoxybenzenesulfonamide
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 177